Skip to main content

Csenge Advisory Group

SEC CIK
0001715593
Latest filing
Aug 10, 2026

LLY holding history

Eli Lilly & Co in every 13F filed by Csenge Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LLY overviewAll 13F holders of LLYFull Q2 2026 holdings

Shares (Q2 2026)
5,327
Value
$6.39M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of LLY by Csenge Advisory Group, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,327$6.39M0.3%+1,398+35.6%AddedHolders
Q1 20263,929$3.61M0.2%+438+12.5%AddedHolders
Q4 20253,491$3.75M0.2%−419−10.7%ReducedHolders
Q3 20253,910$2.98M0.1%−810−17.2%ReducedHolders
Q2 20254,720$3.48M0.2%+389+9.0%AddedHolders
Q1 20254,331$3.64M0.2%−273−5.9%ReducedHolders
Q4 20244,604$3.55M0.2%−1,370−22.9%ReducedHolders
Q3 20245,974$5.57M0.3%+408+7.3%AddedHolders
Q2 20245,566$5.04M0.3%+421+8.2%AddedHolders
Q1 20245,145$4.00M0.2%+933+22.2%AddedHolders
Q4 20234,212$2.46M0.2%+73+1.8%AddedHolders
Q3 20234,139$2.22M0.2%+9+0.2%AddedHolders
Q2 20234,130$1.94M0.1%+669+19.3%AddedHolders
Q1 20233,461$1.19M0.1%−14−0.4%ReducedHolders
Q4 20223,475$1.27M0.1%−560−13.9%ReducedHolders
Q3 20224,035$1.30M0.1%+26+0.6%AddedHolders
Q2 20224,009$1.30M0.1%+332+9.0%AddedHolders
Q1 20223,677$1.05M0.1%+1,002+37.5%AddedHolders
Q4 20212,675$618.0K0.1%−1,655−38.2%ReducedHolders
Q3 20214,330$994.0K0.1%+1,655+61.9%AddedHolders
Q2 20212,675$618.0K0.1%−742−21.7%ReducedHolders
Q1 20213,417$630.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.